ENSURING THE FDA FULLY EXAMINES CLINICAL TRIAL IMPACT AND VITALNESS BEFORE ENDORSEMENT (EFFECTIVE) ACT

Bills and resolutions

Enact (see S. 607), S568 [1MR] (see H.R. 1375), H1113 [3MR]